Excellence in Drug Discovery Consulting
Francesco G. Salituro, Ph.D., currently the Founder and sole proprietor of Salituro MedChem Solutions, LLC, has been a scientific leader in pharmaceutical industry for over 34 years and has successfully driven drug discovery programs across multiple therapeutic areas. His work has resulted in 20 small molecule clinical candidates, including Zuranolone (SAGE-217), SAGE-718, SAGE-324, SAGE-904, Mitapivat, Neflamopimod, Decernotinib, Pimodivir, and three marketed drugs, Zulresso®, IDHIFA® and TIBSOVO®.
“It is not our differences that divide us, it is our inability to recognize, accept, and celebrate those differences.”
— Audre Lorde